Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.10

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, versus ($0.10) reported last year. Revenue for the quarter came in at $9.3 million, versus $8.05 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Freeport-McMoRan shares surge as copper hits record $14,694/ton
• Barnes & Noble Education (BNED) Tops Q1 EPS by 12c